Abstract

Mycoplasma pneumoniae (MP) is one of the main causes of both upper and lower respiratory infections in school-aged children, accounting for up to 40% of community-acquired pneumonia. Younger children are also affected, and extrapulmonary manifestations have been recently reported in the pediatric population. We carried out a retrospective analysis of MP-positive patients admitted to the Pediatric Emergency Unit of S. Orsola Malpighi University Hospital in Bologna, the largest tertiary pediatric referral center in the Emilia–Romagna region, Northern Italy, between 2012 and 2020. We identified 145 patients with MP infection (82 males and 63 females), 27% of which were younger than 2 years; the median age was 5 years (interquartile range 1–9). The clinical presentation partially differed between age groups. School-aged children were more likely to have a chest X-ray-confirmed pneumonia (p = 0.013), while younger children required oxygen therapy more often (p = 0.048). Seventy-four children (51%) showed extrapulmonary manifestations, mainly gastrointestinal (30%) and dermatological (14%). Neurological symptoms were more frequent in children older than 6 years (p = 0.006). The rate of other extrapulmonary manifestations did not differ significantly between age groups. This study shows that MP infection is a frequent cause of pediatric hospitalization, including of children younger than 2 years. Clinicians should be aware of the variable clinical expressions of MP, including extrapulmonary manifestations, to achieve a correct diagnosis and determine appropriate treatment.

Highlights

  • IntroductionMycoplasma pneumoniae (MP) is one of the main causes of respiratory tract infections, accounting for up to 40% of pediatric community-acquired pneumonia (CAP), of which

  • Mycoplasma pneumoniae (MP) is one of the main causes of respiratory tract infections, accounting for up to 40% of pediatric community-acquired pneumonia (CAP), of which18% requires hospitalization [1]

  • The distribution of MP infection according to age, which peaked at age 0–1 year, is reported

Read more

Summary

Introduction

Mycoplasma pneumoniae (MP) is one of the main causes of respiratory tract infections, accounting for up to 40% of pediatric community-acquired pneumonia (CAP), of which. 18% requires hospitalization [1]. Infections appear to be more frequent in winter and autumn, with epidemic outbreaks occurring cyclically worldwide every 3–7 years [2,3]. MP involves school-aged (6–15 years old) children more frequently than younger children, who appear to be less susceptible to infection [4]. The most frequent manifestations are fever, cough (typically non-productive), and dyspnea. Other signs and symptoms that may accompany the infection are rhinorrhea, pharyngitis (typically without exudate), and otitis. Chest pain may be present, it is less-often reported, and is attributable to the often prolonged cough [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call